Abstract
Background Isolation space must be expanded during pandemics involving airborne transmission. Little to no work has been done to establish optimal design strategies and implementation plans to ease surge capacity and expand isolation capacity over long periods in congregate living facilities. The COVID-19 pandemic has an airborne transmission component and requires isolation, which is difficult to accomplish in skilled nursing facilities.
Purpose In this study we designed, implemented, and validated an isolation space at a skilled nursing facility in Lancaster, PA. The overall goal was to minimize disease transmission between residents and staff within the facility.
Basic Procedures We created an isolation space by modifying an existing HVAC system of the SNF. We measured pressure on-site and performed computational fluid dynamics and Lagrangian particle-based modeling to test containment and possible transmission extent given the isolation space is considered negative rather than individual rooms.
Main Findings Pressure data shows the isolation space maintained an average hourly value of (standard deviation) -2.3 Pa (0.12 Pa) pressure differential between it and the external hallway connected to the rest of the facility. No transmission of SARS-CoV-2 between residents isolated to the space occurred, nor did any transmission to the staff or other residents occur. The isolation space was successfully implemented and, as of writing, continues to be operational through the pandemic.
Highlights
Negative pressure isolation space is an effective method to meet needed surge capacity during the COVID-19 pandemic and future pandemics
Planning for how and where to rapidly create a negative pressure isolation space is needed in congregate living areas such as skilled nursing facilities
This demonstration shows the feasibility of using low-cost and in-house systems to quickly create negative pressure within a skilled nursing facility hallway and to maintain these conditions, minimizing disease transmission between residents and staff
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: Implementation funding was provided by Therapy Trip, as well as by Goodville Mutual Casualty Company.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The COVID Task Force was the acting oversight body at the Fairmount Homes and responsible for the decision making processes associated with responding to the SARS-CoV-2 pandemic. The Task Force members included the medical director, administrative team, environmental director, Human Resources director, and director of nursing. on 3/30/20, this research was approved by the Fairmount Homes COVID Task force.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Implementation funding was provided by Therapy Trip, as well as by Goodville Mutual Casualty Company.
Data Availability
Data is available upon request.
